1 Lifestyle Drugs Market Overview

• 1.1 Product Overview and Scope of Lifestyle Drugs
• 1.2 Lifestyle Drugs Segment by Therapeutic Type
  • 1.2.1 Global Lifestyle Drugs Sales Growth Rate Comparison by Therapeutic Type (2021-2027)
  • 1.2.2 Depression
  • 1.2.3 Dermatology
  • 1.2.4 Sexual Dysfunction
  • 1.2.5 Obesity
  • 1.2.6 Others
• 1.3 Lifestyle Drugs Segment by Sales Channel
  • 1.3.1 Lifestyle Drugs Sales Comparison by Sales Channel: (2021-2027)
  • 1.3.2 Hospital Pharmacies
  • 1.3.3 Retail Pharmacies
  • 1.3.4 Online Pharmacies
• 1.4 Global Lifestyle Drugs Market Size Estimates and Forecasts
  • 1.4.1 Global Lifestyle Drugs Revenue 2016-2027
  • 1.4.2 Global Lifestyle Drugs Sales 2016-2027
  • 1.4.3 Lifestyle Drugs Market Size by Region: 2016 Versus 2021 Versus 2027

2 Lifestyle Drugs Market Competition by Manufacturers

• 2.1 Global Lifestyle Drugs Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Lifestyle Drugs Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Lifestyle Drugs Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Lifestyle Drugs Manufacturing Sites, Area Served, Product Type
• 2.5 Lifestyle Drugs Market Competitive Situation and Trends
  • 2.5.1 Lifestyle Drugs Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Lifestyle Drugs Players Market Share by Revenue
  • 2.5.3 Global Lifestyle Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Lifestyle Drugs Retrospective Market Scenario by Region

• 3.1 Global Lifestyle Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Lifestyle Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Lifestyle Drugs Market Facts & Figures by Country
  • 3.3.1 North America Lifestyle Drugs Sales by Country
  • 3.3.2 North America Lifestyle Drugs Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Lifestyle Drugs Market Facts & Figures by Country
  • 3.4.1 Europe Lifestyle Drugs Sales by Country
  • 3.4.2 Europe Lifestyle Drugs Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Lifestyle Drugs Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Lifestyle Drugs Sales by Region
  • 3.5.2 Asia Pacific Lifestyle Drugs Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Lifestyle Drugs Market Facts & Figures by Country
  • 3.6.1 Latin America Lifestyle Drugs Sales by Country
  • 3.6.2 Latin America Lifestyle Drugs Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Lifestyle Drugs Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Lifestyle Drugs Sales by Country
  • 3.7.2 Middle East and Africa Lifestyle Drugs Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 U.A.E

4 Global Lifestyle Drugs Historic Market Analysis by Type

• 4.1 Global Lifestyle Drugs Sales Market Share by Type (2016-2021)
• 4.2 Global Lifestyle Drugs Revenue Market Share by Type (2016-2021)
• 4.3 Global Lifestyle Drugs Price by Type (2016-2021)

5 Global Lifestyle Drugs Historic Market Analysis by Sales Channel

• 5.1 Global Lifestyle Drugs Sales Market Share by Sales Channel (2016-2021)
• 5.2 Global Lifestyle Drugs Revenue Market Share by Sales Channel (2016-2021)
• 5.3 Global Lifestyle Drugs Price by Sales Channel (2016-2021)

6 Key Companies Profiled

• 6.1 Allergan
  • 6.1.1 Allergan Corporation Information
  • 6.1.2 Allergan Description and Business Overview
  • 6.1.3 Allergan Lifestyle Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Allergan Product Portfolio
  • 6.1.5 Allergan Recent Developments/Updates
• 6.2 Eli Lilly
  • 6.2.1 Eli Lilly Corporation Information
  • 6.2.2 Eli Lilly Description and Business Overview
  • 6.2.3 Eli Lilly Lifestyle Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Eli Lilly Product Portfolio
  • 6.2.5 Eli Lilly Recent Developments/Updates
• 6.3 Pfizer
  • 6.3.1 Pfizer Corporation Information
  • 6.3.2 Pfizer Description and Business Overview
  • 6.3.3 Pfizer Lifestyle Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Pfizer Product Portfolio
  • 6.3.5 Pfizer Recent Developments/Updates
• 6.4 AstraZeneca
  • 6.4.1 AstraZeneca Corporation Information
  • 6.4.2 AstraZeneca Description and Business Overview
  • 6.4.3 AstraZeneca Lifestyle Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 AstraZeneca Product Portfolio
  • 6.4.5 AstraZeneca Recent Developments/Updates
• 6.5 Teva
  • 6.5.1 Teva Corporation Information
  • 6.5.2 Teva Description and Business Overview
  • 6.5.3 Teva Lifestyle Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Teva Product Portfolio
  • 6.5.5 Teva Recent Developments/Updates
• 6.6 Sun Pharmacetuicals
  • 6.6.1 Sun Pharmacetuicals Corporation Information
  • 6.6.2 Sun Pharmacetuicals Description and Business Overview
  • 6.6.3 Sun Pharmacetuicals Lifestyle Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Sun Pharmacetuicals Product Portfolio
  • 6.6.5 Sun Pharmacetuicals Recent Developments/Updates
• 6.7 Merck
  • 6.6.1 Merck Corporation Information
  • 6.6.2 Merck Description and Business Overview
  • 6.6.3 Merck Lifestyle Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Merck Product Portfolio
  • 6.7.5 Merck Recent Developments/Updates
• 6.8 Forendo Pharma
  • 6.8.1 Forendo Pharma Corporation Information
  • 6.8.2 Forendo Pharma Description and Business Overview
  • 6.8.3 Forendo Pharma Lifestyle Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Forendo Pharma Product Portfolio
  • 6.8.5 Forendo Pharma Recent Developments/Updates
• 6.9 Avolynt
  • 6.9.1 Avolynt Corporation Information
  • 6.9.2 Avolynt Description and Business Overview
  • 6.9.3 Avolynt Lifestyle Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 Avolynt Product Portfolio
  • 6.9.5 Avolynt Recent Developments/Updates
• 6.10 Alkermes
  • 6.10.1 Alkermes Corporation Information
  • 6.10.2 Alkermes Description and Business Overview
  • 6.10.3 Alkermes Lifestyle Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 Alkermes Product Portfolio
  • 6.10.5 Alkermes Recent Developments/Updates
• 6.11 Dong-A ST
  • 6.11.1 Dong-A ST Corporation Information
  • 6.11.2 Dong-A ST Lifestyle Drugs Description and Business Overview
  • 6.11.3 Dong-A ST Lifestyle Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.11.4 Dong-A ST Product Portfolio
  • 6.11.5 Dong-A ST Recent Developments/Updates
• 6.12 Dermira
  • 6.12.1 Dermira Corporation Information
  • 6.12.2 Dermira Lifestyle Drugs Description and Business Overview
  • 6.12.3 Dermira Lifestyle Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.12.4 Dermira Product Portfolio
  • 6.12.5 Dermira Recent Developments/Updates
• 6.13 Avanir Pharmaceuticals
  • 6.13.1 Avanir Pharmaceuticals Corporation Information
  • 6.13.2 Avanir Pharmaceuticals Lifestyle Drugs Description and Business Overview
  • 6.13.3 Avanir Pharmaceuticals Lifestyle Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.13.4 Avanir Pharmaceuticals Product Portfolio
  • 6.13.5 Avanir Pharmaceuticals Recent Developments/Updates
• 6.14 Menlo Therapeutics
  • 6.14.1 Menlo Therapeutics Corporation Information
  • 6.14.2 Menlo Therapeutics Lifestyle Drugs Description and Business Overview
  • 6.14.3 Menlo Therapeutics Lifestyle Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.14.4 Menlo Therapeutics Product Portfolio
  • 6.14.5 Menlo Therapeutics Recent Developments/Updates
• 6.15 Galderma
  • 6.15.1 Galderma Corporation Information
  • 6.15.2 Galderma Lifestyle Drugs Description and Business Overview
  • 6.15.3 Galderma Lifestyle Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.15.4 Galderma Product Portfolio
  • 6.15.5 Galderma Recent Developments/Updates
• 6.16 Cerecor
  • 6.16.1 Cerecor Corporation Information
  • 6.16.2 Cerecor Lifestyle Drugs Description and Business Overview
  • 6.16.3 Cerecor Lifestyle Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.16.4 Cerecor Product Portfolio
  • 6.16.5 Cerecor Recent Developments/Updates
• 6.17 Corcept Therapeutics
  • 6.17.1 Corcept Therapeutics Corporation Information
  • 6.17.2 Corcept Therapeutics Lifestyle Drugs Description and Business Overview
  • 6.17.3 Corcept Therapeutics Lifestyle Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.17.4 Corcept Therapeutics Product Portfolio
  • 6.17.5 Corcept Therapeutics Recent Developments/Updates
• 6.18 Anterios
  • 6.18.1 Anterios Corporation Information
  • 6.18.2 Anterios Lifestyle Drugs Description and Business Overview
  • 6.18.3 Anterios Lifestyle Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.18.4 Anterios Product Portfolio
  • 6.18.5 Anterios Recent Developments/Updates
• 6.19 Euthymics Bioscience
  • 6.19.1 Euthymics Bioscience Corporation Information
  • 6.19.2 Euthymics Bioscience Lifestyle Drugs Description and Business Overview
  • 6.19.3 Euthymics Bioscience Lifestyle Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.19.4 Euthymics Bioscience Product Portfolio
  • 6.19.5 Euthymics Bioscience Recent Developments/Updates
• 6.20 Cosmo Pharmaceuticals
  • 6.20.1 Cosmo Pharmaceuticals Corporation Information
  • 6.20.2 Cosmo Pharmaceuticals Lifestyle Drugs Description and Business Overview
  • 6.20.3 Cosmo Pharmaceuticals Lifestyle Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.20.4 Cosmo Pharmaceuticals Product Portfolio
  • 6.20.5 Cosmo Pharmaceuticals Recent Developments/Updates
• 6.21 AndroScience
  • 6.21.1 AndroScience Corporation Information
  • 6.21.2 AndroScience Lifestyle Drugs Description and Business Overview
  • 6.21.3 AndroScience Lifestyle Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.21.4 AndroScience Product Portfolio
  • 6.21.5 AndroScience Recent Developments/Updates
• 6.22 Acerus Pharmaceuticals
  • 6.22.1 Acerus Pharmaceuticals Corporation Information
  • 6.22.2 Acerus Pharmaceuticals Lifestyle Drugs Description and Business Overview
  • 6.22.3 Acerus Pharmaceuticals Lifestyle Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.22.4 Acerus Pharmaceuticals Product Portfolio
  • 6.22.5 Acerus Pharmaceuticals Recent Developments/Updates
• 6.23 Celtaxsys
  • 6.23.1 Celtaxsys Corporation Information
  • 6.23.2 Celtaxsys Lifestyle Drugs Description and Business Overview
  • 6.23.3 Celtaxsys Lifestyle Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.23.4 Celtaxsys Product Portfolio
  • 6.23.5 Celtaxsys Recent Developments/Updates
• 6.24 Futura Medical Developments
  • 6.24.1 Futura Medical Developments Corporation Information
  • 6.24.2 Futura Medical Developments Lifestyle Drugs Description and Business Overview
  • 6.24.3 Futura Medical Developments Lifestyle Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.24.4 Futura Medical Developments Product Portfolio
  • 6.24.5 Futura Medical Developments Recent Developments/Updates
• 6.25 Follicum
  • 6.25.1 Follicum Corporation Information
  • 6.25.2 Follicum Lifestyle Drugs Description and Business Overview
  • 6.25.3 Follicum Lifestyle Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.25.4 Follicum Product Portfolio
  • 6.25.5 Follicum Recent Developments/Updates

7 Lifestyle Drugs Manufacturing Cost Analysis

• 7.1 Lifestyle Drugs Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Lifestyle Drugs
• 7.4 Lifestyle Drugs Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Lifestyle Drugs Distributors List
• 8.3 Lifestyle Drugs Customers

9 Lifestyle Drugs Market Dynamics

• 9.1 Lifestyle Drugs Industry Trends
• 9.2 Lifestyle Drugs Growth Drivers
• 9.3 Lifestyle Drugs Market Challenges
• 9.4 Lifestyle Drugs Market Restraints

10 Global Market Forecast

• 10.1 Lifestyle Drugs Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Lifestyle Drugs by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Lifestyle Drugs by Type (2022-2027)
• 10.2 Lifestyle Drugs Market Estimates and Projections by Sales Channel
  • 10.2.1 Global Forecasted Sales of Lifestyle Drugs by Sales Channel (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Lifestyle Drugs by Sales Channel (2022-2027)
• 10.3 Lifestyle Drugs Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Lifestyle Drugs by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Lifestyle Drugs by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
by Therapeutic Type
Depression
Dermatology
Sexual Dysfunction
Obesity
Others
by Form
Tablet
Gel
Cream
Oral Syrups
Parenteral
Others

Segment by Sales Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Allergan
Eli Lilly
Pfizer
AstraZeneca
Teva
Sun Pharmacetuicals
Merck
Forendo Pharma
Avolynt
Alkermes
Dong-A ST
Dermira
Avanir Pharmaceuticals
Menlo Therapeutics
Galderma
Cerecor
Corcept Therapeutics
Anterios
Euthymics Bioscience
Cosmo Pharmaceuticals
AndroScience
Acerus Pharmaceuticals
Celtaxsys
Futura Medical Developments
Follicum